Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study (2021)
Attributed to:
Dose rationale for antibiotic combination therapy in infection diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-052885
PubMed Identifier: 34244287
Publication URI: http://europepmc.org/abstract/MED/34244287
Type: Journal Article/Review
Parent Publication: BMJ Open
Issue: 7
ISSN: 2044-6055